Global Vaccines Market Size study, By Type (Conjugate vaccines, Inactivated and subunit vaccines, Live attenuated vaccines, Recombinant vaccines, Toxoid vaccines), By Technology (Monovalent vaccines, Multivalent vaccines), By Disease Indication (Pneumococcal disease, DTP, Influenza, HPV, Meningococcal disease, Polio, Rotavirus, Hepatitis, MMR, Varicella, Herpes zoster, Other disease indications), By Route of Administration (Intramuscular and subcutaneous administration, Oral administration, Other routes of administration), By Patient Type (Pediatric patients, Adult patients), and Regional Forecasts 2022-2028
- BIZ4952997
- 200 Pages
- April 2022
- Pharmaceuticals
The key regions considered for the global Vaccines market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to growing investments by the various non-government and government organizations for vaccine development and the high prevalence of infectious diseases. Whereas, Asia-Pacific is also anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as rising government initiatives, growing healthcare expenditure, and the presence of a large patient population would create lucrative growth prospects for the Vaccines market across the Asia-Pacific region.
Major market players included in this report are:
GlaxoSmithKline plc
Pfizer, Inc.
Sanofi Pasteur
Merck & Co., Inc.
CSL Limited
Emergent BioSolutions, Inc.
Johnson & Johnson
Serum Institute of India Pvt. Ltd.
Mitsubishi Tanabe Pharma Corporation
Panacea Biotec
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Type offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Conjugate vaccines
Inactivated and subunit vaccines
Live attenuated vaccines
Recombinant vaccines
Toxoid vaccines
By Technology:
Monovalent vaccines
Multivalent vaccines
By Disease Indication:
Pneumococcal disease
DTP
Influenza
HPV
Meningococcal disease
Polio
Rotavirus
Hepatitis
MMR
Varicella
Herpes zoster
Other disease indications
By Route of Administration:
Intramuscular and subcutaneous administration
Oral administration
Other routes of administration
By Patient Type:
Pediatric patients
Adult patients
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Vaccines Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028(USD Billion)
1.2.1. Vaccines Market, by Region, 2020-2028(USD Billion)
1.2.2. Vaccines Market, by Type, 2020-2028(USD Billion)
1.2.3. Vaccines Market, by Technology, 2020-2028(USD Billion)
1.2.4. Vaccines Market, by Disease Indication, 2020-2028(USD Billion)
1.2.5. Vaccines Market, by Route of Administration, 2020-2028(USD Billion)
1.2.6. Vaccines Market, by Patient Type, 2020-2028(USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Vaccines Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Vaccines Market Dynamics
3.1. Vaccines Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing prevalence of emerging and re-emerging infectious diseases
3.1.1.2. Increasing government support for vaccine development
3.1.2. Market Challenges
3.1.2.1. High cost of vaccine development
3.1.3. Market Opportunities
3.1.3.1. Rising inclination on therapeutic vaccines
Chapter 4. Global Vaccines Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Vaccines Market, by Type
6.1. Market Snapshot
6.2. Global Vaccines Market by Type, Performance - Potential Analysis
6.3. Global Vaccines Market Estimates & Forecasts by Type, 2019-2028 (USD Billion)
6.4. Vaccines Market, Sub Segment Analysis
6.4.1. Conjugate Vaccines
6.4.2. Inactivated and Subunit Vaccines
6.4.3. Live Attenuated Vaccines
6.4.4. Recombinant Vaccines
6.4.5. Toxoid Vaccines
Chapter 7. Global Vaccines Market, by Technology
7.1. Market Snapshot
7.2. Global Vaccines Market by Technology, Performance – Potential Analysis
7.3. Global Vaccines Market Estimates & Forecasts by Technology, 2019-2028 (USD Billion)
7.4. Vaccines Market, Sub Segment Analysis
7.4.1. Monovalent vaccines
7.4.2. Multivalent vaccines
Chapter 8. Global Vaccines Market, by Disease Indication
8.1. Market Snapshot
8.2. Global Vaccines Market by Disease Indication, Performance - Potential Analysis
8.3. Global Vaccines Market Estimates & Forecasts by Disease Indication, 2019-2028 (USD Billion)
8.4. Vaccines Market, Sub Segment Analysis
8.4.1. Pneumococcal disease
8.4.2. DTP
8.4.3. Influenza
8.4.4. HPV
8.4.5. Meningococcal disease
8.4.6. Polio
8.4.7. Rotavirus
8.4.8. Hepatitis
8.4.9. MMR
8.4.10. Varicella
8.4.11. Herpes zoster
8.4.12. Other disease indications
Chapter 9. Global Vaccines Market, by Route of Administration
9.1. Market Snapshot
9.2. Global Vaccines Market by Route of Administration, Performance - Potential Analysis
9.3. Global Vaccines Market Estimates & Forecasts by Route of Administration, 2019-2028 (USD Billion)
9.4. Vaccines Market, Sub Segment Analysis
9.4.1. Intramuscular and subcutaneous administration
9.4.2. Oral administration
9.4.3. Other routes of administration
Chapter 10. Global Vaccines Market, by Patient Type
10.1. Market Snapshot
10.2. Global Vaccines Market by Patient Type, Performance - Potential Analysis
10.3. Global Vaccines Market Estimates & Forecasts by Patient Type, 2019-2028 (USD Billion)
10.4. Vaccines Market, Sub Segment Analysis
10.4.1. Pediatric patients
10.4.2. Adult patients
Chapter 11. Global Vaccines Market, Regional Analysis
11.1. Vaccines Market, Regional Market Snapshot
11.2. North America Vaccines Market
11.2.1. U.S. Vaccines Market
11.2.1.1. Type breakdown estimates & forecasts, 2019-2028
11.2.1.2. Technology breakdown estimates & forecasts, 2019-2028
11.2.1.3. Disease Indication breakdown estimates & forecasts, 2019-2028
11.2.1.4. Route of Administration breakdown estimates & forecasts, 2019-2028
11.2.1.5. Patient Type breakdown estimates & forecasts, 2019-2028
11.2.2. Canada Vaccines Market
11.3. Europe Vaccines Market Snapshot
11.3.1. U.K. Vaccines Market
11.3.2. Germany Vaccines Market
11.3.3. France Vaccines Market
11.3.4. Spain Vaccines Market
11.3.5. Italy Vaccines Market
11.3.6. Rest of Europe Vaccines Market
11.4. Asia-Pacific Vaccines Market Snapshot
11.4.1. China Vaccines Market
11.4.2. India Vaccines Market
11.4.3. Japan Vaccines Market
11.4.4. Australia Vaccines Market
11.4.5. South Korea Vaccines Market
11.4.6. Rest of Asia Pacific Vaccines Market
11.5. Latin America Vaccines Market Snapshot
11.5.1. Brazil Vaccines Market
11.5.2. Mexico Vaccines Market
11.6. Rest of The World Vaccines Market
Chapter 12. Competitive Intelligence
12.1. Top Market Strategies
12.2. Company Profiles
12.2.1. GlaxoSmithKline plc
12.2.1.1. Key Information
12.2.1.2. Overview
12.2.1.3. Financial (Subject to Data Availability)
12.2.1.4. Type Summary
12.2.1.5. Recent Developments
12.2.2. Pfizer, Inc.
12.2.3. Sanofi Pasteur
12.2.4. Merck & Co., Inc.
12.2.5. CSL Limited
12.2.6. Emergent BioSolutions, Inc.
12.2.7. Johnson & Johnson
12.2.8. Serum Institute of India Pvt. Ltd.
12.2.9. Mitsubishi Tanabe Pharma Corporation
12.2.10. Panacea Biotec
Chapter 13. Research Process
13.1. Research Process
13.1.1. Data Mining
13.1.2. Analysis
13.1.3. Market Estimation
13.1.4. Validation
13.1.5. Publishing
13.2. Research Attributes
13.3. Research Assumption
TABLE 1. Global Vaccines market, report scope
TABLE 2. Global Vaccines market estimates & forecasts by Region 2019-2028 (USD Billion)
TABLE 3. Global Vaccines market estimates & forecasts by Type 2019-2028 (USD Billion)
TABLE 4. Global Vaccines market estimates & forecasts by Technology 2019-2028 (USD Billion)
TABLE 5. Global Vaccines market estimates & forecasts by Disease Indication 2019-2028 (USD Billion)
TABLE 6. Global Vaccines market estimates & forecasts by Route of Administration 2019-2028 (USD Billion)
TABLE 7. Global Vaccines market estimates & forecasts by Patient Type 2019-2028 (USD Billion)
TABLE 8. Global Vaccines market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 9. Global Vaccines market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 10. Global Vaccines market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 11. Global Vaccines market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 12. Global Vaccines market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 13. Global Vaccines market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 14. Global Vaccines market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 15. Global Vaccines market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 16. Global Vaccines market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 17. Global Vaccines market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 18. U.S. Vaccines market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 19. U.S. Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 20. U.S. Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 21. Canada Vaccines market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 22. Canada Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 23. Canada Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 24. UK Vaccines market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 25. UK Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 26. UK Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 27. Germany Vaccines market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 28. Germany Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 29. Germany Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 30. RoE Vaccines market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 31. RoE Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 32. RoE Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 33. China Vaccines market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 34. China Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 35. China Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 36. India Vaccines market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 37. India Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 38. India Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 39. Japan Vaccines market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 40. Japan Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 41. Japan Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 42. RoAPAC Vaccines market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 43. RoAPAC Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 44. RoAPAC Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 45. Brazil Vaccines market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 46. Brazil Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 47. Brazil Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 48. Mexico Vaccines market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 49. Mexico Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 50. Mexico Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 51. RoLA Vaccines market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 52. RoLA Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 53. RoLA Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 54. Row Vaccines market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 55. Row Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 56. Row Vaccines market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 57. List of secondary sources, used in the study of global Vaccines market
TABLE 58. List of primary sources, used in the study of global Vaccines market
TABLE 59. Years considered for the study
TABLE 60. Exchange rates considered
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
